Download PDF
Hamostaseologie 1982; 02(01): 8-17
DOI: 10.1055/s-0038-1656389
Originalarbeiten
Schattauer GmbH

Grenzen und Möglichkeiten der Therapie von Rhythmusstörungen im Hinblick auf den plötzlichen Herztod

H. Mösslacher
1   I. Medizinischen Univ.-Klinik Wien (Vorstand: Prof. Dr. Dr. h. c. E. Deutsch)
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • LITERATUR

  • 1 Kuller L., Lilienfeld A., Fisher R.. Epidemiological study of sudden and unexpected deaths due to arteriosclerotic heart disease. Circulation 1966; 34: 1056-1068
    CrossrefPubMedGoogle Scholar
  • 2 Lown B.. Sudden cardiac death: The major challenge confronting contemporary cardiology. Am. J. Cardiol. 1979; 43: 313-328
    CrossrefPubMedGoogle Scholar
  • 3 Pantridge J., Geddes S.. A mobile intensive care unit in the management of myocardial infarction. Lancet 1967; 2: 271
    PubMedGoogle Scholar
  • 4 Pantridge J. F.. Prehospital coronary care. Brit. Heart J. 1974; 26: 233-237
    PubMedGoogle Scholar
  • 5 Iseri L., Humphrey S.. Prehospital brady-asysto-lic cardiac arrest. Ann. Intern. Med. 1978; 88: 741
    CrossrefPubMedGoogle Scholar
  • 6 Adgey A. A. J., Geddes J. S., Mülholland H. C., Keegan D. A. J., Pantridge J. F.. Incidence. significance and management of early brady-arrhythmias complicating acute myocardial infarction. Lancet 1968; 2: 1097
    PubMedGoogle Scholar
  • 7 Bashe W. J., Baba N.. et al. Pathology of atherosclerotic heart disease in sudden death. II: The significance of myocardial infarction. Circulation 1975; 51/52 (Suppl. III) 63
    PubMedGoogle Scholar
  • 8 Baroldi G., Falzi G., Mariani F.. Sudden coronary death. A postmortem study in 208 selected cases compared to 97 »control« subjects. Am. Heart J. 1979; 98: 20-31
    CrossrefPubMedGoogle Scholar
  • 9 Grace W. J.. Sudden death and acute myocardial infarction - what are we talking about (editorial). Am. Heart J. 1976; 91: 1-2
    CrossrefPubMedGoogle Scholar
  • 10 Lown B.. New concepts and approaches to sudden death. Schweiz med. Wschr. 1976; 106: 1522-1531
    PubMedGoogle Scholar
  • 11 Reichenbach D. D., Moss N. S., Meyer E.. Pathology of the heart in sudden death. Am. J. Cardiol. 1977; 39: 865-872
    CrossrefPubMedGoogle Scholar
  • 12 Roberts W. L., Buja L. W.. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. Am. J. Med. 1972; 52: 425
    CrossrefPubMedGoogle Scholar
  • 13 Spain D. M., Brades V. A.. Frequency of coronary thrombi as related to duration of survival from onset of acute fatal episodes of myocardial isch-aemia. Circulation 1960; 22: 816
    PubMedGoogle Scholar
  • 14 Lovegrove T., Thompson P.. The role of acute myocardial infarction in sudden cardiac death - a statistician nightmare. Am. Heart J. 96: 711 1978;
    CrossrefPubMedGoogle Scholar
  • 15 Weaver W. D.. et al Angiographic findings and prognostic indicators in patients resuscitated from sudden death. Circulation 1976; 54: 895
    CrossrefPubMedGoogle Scholar
  • 16 Cobb L. A., Hallstrom A. P.. et al: Prognostic factors in patients resuscitated from sudden cardiac death. In Hjalmarson A. L., Wilhelmsen L.. (eds) Acute and longterm medical treatment of myocardial ischaemia. Hässl, Mölntal 1978
    PubMedGoogle Scholar
  • 17 Schaffer W. A., Cobb L. A.. Recurrent ventricular fibrillation and modes of death in survivors of out of hospital ventricular fibrillation. New Engl. J. Med. 1975; 293: 259-262
    CrossrefPubMedGoogle Scholar
  • 18 Wellens H. J. J., Düren D. R., Lie K. J.. Observations on mechanism of ventricular tachycardia in man. Circulation 1976; 54: 237
    CrossrefPubMedGoogle Scholar
  • 19 Myberg R. J., Steward J. W., Hoffman B. I.. Electrophysical properties of the canine peripheral av - conducting system. Circulation Res. 1970; 26: 361
    CrossrefPubMedGoogle Scholar
  • 20 Lown B., Wolf M.. Approaches to sudden death from coronary heart disease. Circulation 1971; 44: 130
    CrossrefPubMedGoogle Scholar
  • 21 van Durme J. P., Pannier R.. Prevalence and prognostic significance of ventricular dysrhythmias during the first year after myocardial infarction. In Mäurer W. A., Schöming R., Dietz P., Lichtlen R.. (eds.) Betablockade 1977. Thieme; Stuttgart: 1978: 286
    Google Scholar
  • 22 Ruberman W., Weinblatt E.. et al. Prognostic value of one hour of EKG-monitoring of man with coronary heart disease. J. chron. Dis. 1976; 29: 497-512
    CrossrefPubMedGoogle Scholar
  • 23 Schulze R. A., Strauss H. W., Pitt B.. Sudden death in the year following myocardial infarction. Am. J. Med. 1977; 62: 192
    CrossrefPubMedGoogle Scholar
  • 24 Vismara L. A., Amsterdam E. A., Mason D. T.. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death of hospital discharge. Am. J. Med. 1975; 59: 6
    CrossrefPubMedGoogle Scholar
  • 25 The Coronary Drug Project Research Group Prognostic importance of premature beats following myocardial infarction. Experience in the coronary drug project. JAMA 1973; 223: 1116
    PubMedGoogle Scholar
  • 26 Ruberman W. E., Weinblatt E., Goldberg J. D.. et al. Ventricular premature beats and mortality after myocardial infarction. New Engl. J. Med. 1977; 297: 750
    CrossrefPubMedGoogle Scholar
  • 27 El Sherif N., Myerburg R. J., Scherlag J., Befeler B., Aranda J. M., Castellanos A., Lazzara R.. Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R on T-phenomenon in myocardial infarction. Brit. Heart J. 1976; 38: 415
    PubMedGoogle Scholar
  • 28 Bennet M. A., Pentecost B. L.. Warning of cardiac arrest due to ventricular fibrillation and tachycardia. Lancet 1972; 1: 1351
    PubMedGoogle Scholar
  • 29 Lie K. J., Wellens H. J. J., Durrer D.. Characteristics and predictability of primary ventricular fibrillation. Europ. J. Cardiol. 1974; 1: 379
    PubMedGoogle Scholar
  • 30 Lie K. J., Wellens H. J. J., Dorner E., Durrer D.. Observations in patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation 1975; 52: 755
    CrossrefPubMedGoogle Scholar
  • 31 Seipel L.. Warnarrhythmien und Lidocainpro-phylaxe beim Herzinfarkt. Dtsch. med. Wschr. 1977; 102: 1041-1042
    PubMedGoogle Scholar
  • 32 Califf R. M., Burks J. M.. et al. Relationship among ventricular arrhythmias. Coronary artery disease and angiographic and electrocardiographic indicators of myocardial fibrosis. Circulation 1978; 57: 725
    CrossrefPubMedGoogle Scholar
  • 33 Calvert A., Lown B., Gorlin R.. Ventricular premature beats and anatomically defined coronary heart disease. Am. J. Cardiol. 1977; 39: 627-634
    CrossrefPubMedGoogle Scholar
  • 34 Lichtlen P. R., Bethge K. P., Platiel H.. Inzidenz des plötzlichen Herztodes bei Koronarpatienten in Abhängigkeit von Anatomie und Rhythmus-profil. Z. Kardiol. 1980; 69: 639-648
    PubMedGoogle Scholar
  • 35 Sharma S. D., Ballantyne F., Goldstein S.. The relationship of ventricular asynergy in coronary artery disease to ventricular premature beats. Chest 1974; 66: 358-362
    CrossrefPubMedGoogle Scholar
  • 36 Schulze R. A., Humphries J., O'Neal J.. Left ventricular and coronary angiographic anatomy -relationship to ventricular irritability in the late hospital phase of acute myocardial infarction. Circulation 1977; 55: 839
    CrossrefPubMedGoogle Scholar
  • 37 Matta R. J., Verrier R. L., Lown B.. The repetitive extrasystole as an index of vulnerability to ventricular fibrillation. Am. J. Physiol. 1976; 230: 1469
    PubMedGoogle Scholar
  • 38 Maseri A., L'Abbate A., Baroldi G.. et al. Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from study of preinfarction angina. New Engl. J. Med. 1978; 229: 1271-1277
    PubMedGoogle Scholar
  • 39 Maseri A.. et al. »Variant« angina: one aspect of a continous spectrum of vasospastic myocardial ischaemia. Am. J. Cardiol. 1978; 42: 1019
    CrossrefPubMedGoogle Scholar
  • 40 Maseri A., Chierchia S., L'Abbate A.. Pathogenetic mechanism underlying the clinical events associated with atherosclerotic heart disease. Circulation 1980; 62 (Suppl. V) 3-13
    PubMedGoogle Scholar
  • 41 Lown B., Verrier R. L.. Neural activity and ventricular fibrillation. New Engl. J. Med. 1976; 294: 1165-1170
    CrossrefPubMedGoogle Scholar
  • 42 Lown B., Verrier R. C., Rabinowitz S. J.. Neural and psychologic mechanism and the problem of sudden cardiac death. Am. J. Cardiol. 1977; 39: 890-902
    CrossrefPubMedGoogle Scholar
  • 43 Engel G. L.. Sudden death and rapid death during psychologic stress. Folklore or folk wisdom. Ann. intern. Med. 1971; 74: 771-782
    PubMedGoogle Scholar
  • 44 Taggart P., Carruthers M., Somerville W.. Electrocardiograms. plasma catecholamines and lipids and their modification by Oxprenolol when speaking before an audience. Lancet 1973; 2: 341-346
    PubMedGoogle Scholar
  • 45 Cobb L. A., Werner J. A.. Antiarrhythmic therapy. Ventricular depolarization and sudden death. The tip of the iceberg (editorial). Circulation 1979; 59: 864-865
    PubMedGoogle Scholar
  • 46 Valentine P. A.. Lidocain in the prevention of sudden death in the prehospital phase of acute myocardial infarction. New Engl. J. Med. 1974; 291: 1327-1331
    CrossrefPubMedGoogle Scholar
  • 47 Singh J. B., Kocot S. L.. A controlled trial of intramuscular lidocain in the prevention of premature ventricular contractions associated with acute myocardial infarction. Am. Heart J. 1976; 91: 430
    CrossrefPubMedGoogle Scholar
  • 48 Lie K. J., Liem K. L., Louridzt W. J., Janse M. J., Willebrands A. F., Durrer D.. Efficacy of lidocain in preventing primary fibrillation within 1 hour after a 300 mg intramuscular injection. A double blind, randomized study of 300 hospitalized patients with acute myocardial infarction. Am. J. Cardiol. 1978; 42: 486
    PubMedGoogle Scholar
  • 49 Bernstein V., Bernstein M., Griffith J.. et al. Lidocain intramusculary in acute myocardial infarction. JAMA 1972; 279: 1027-1031
    PubMedGoogle Scholar
  • 50 Cohen L. S., Rosenthal J. E.. et al. Plasma levels of lignocaine after intramuscular administration. Am. J. Cardiol. 1972; 29: 520-523
    CrossrefPubMedGoogle Scholar
  • 51 Ryden L., Wasir H., Conradsson T. B.. et al. Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction. Brit. Heart J. 1972; 34: 1012-1017
    CrossrefPubMedGoogle Scholar
  • 52 Scott D. B., Vellani C. W., Jebson P. J.. et al. Plasma levels of lignocaine after intramuscular injection. Lancet 1968; 2: 1209-1210
    PubMedGoogle Scholar
  • 53 Zener J. C., Kerber R. E., Spivak A. P., Harrison D. C.. Blood lidocain levels and kinetics following highdose intramuscular administration. Circulation 1973; 47: 984
    CrossrefPubMedGoogle Scholar
  • 54 Ribner H. S., Isaacs E. S., Frishman W. H.. Lidocain prophylaxis against ventricular fibrillation in acute myocardial infarction. Prog. Cardio-vasc. Dis. 1979; 21: 287
    CrossrefPubMedGoogle Scholar
  • 55 Lie K. J., Wellens H. J. J., van Capelle F. J., Durrer D.. Lidocaine in the prevention of primary ventricular fibrillation. A double blind randomized study of 212 consecutive patients. New Engl. J. Med. 1974; 291: 1324
    PubMedGoogle Scholar
  • 56 Harrison D. C. Should lidocain be administered routinely to all patients after acute myocardial infarction? (editorial). Circulation 1978; 58: 581-584
    CrossrefPubMedGoogle Scholar
  • 57 Killip T.. Arrhythmias in myocardial infarction. Med. Clin. N. Amer. 1976; 60: 233
    PubMedGoogle Scholar
  • 58 Scheinman M. M., Remedios P., Cheitlin M. D.. et al. Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction. Circulation 1980; 62: 20
    CrossrefPubMedGoogle Scholar
  • 59 Rudolph W., Dirschinger J.. Standardtherapie des akuten Myocardinfarktes. Herz 1981; 6: 1-13
    PubMedGoogle Scholar
  • 60 Barber J. M., Mc D. C., Boyle HussainZ.. et al. Simple lignocaine regimen for transit to hospital after myocardial infarction. Brit. Heart J. 1977; 39: 1361
    CrossrefPubMedGoogle Scholar
  • 61 Ryden L., Waldenstrom A.. et al. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmias complicating acute myocardial infarction. Brit. Heart J. 1973; 35: 1124-1131
    CrossrefPubMedGoogle Scholar
  • 62 Campbell N. P. S., Kelly J. G., Adgey A. A. J., McDevitt D. G., Pantridge J. F.. Observations on intravenous administration of lignocaine in patients with myocardial infarction. 1978; Brit. Heart J. 40: 1371
    CrossrefPubMedGoogle Scholar
  • 63 Sheridan D. J., Crawford L., Rawlins M. D., Julian D. G.. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration. Lancet 1977; 1: 824
    PubMedGoogle Scholar
  • 64 Bleifeld W., Merx W., Heimich K. W., Effert S.. Lidocain zur Arrhythmieprophylaxe beim frischen Herzinfarkt. Verh. dtsch. Ges. inn. Med. 1972; 78: 1035
    PubMedGoogle Scholar
  • 65 Jennings G., Model D. C., Jones M. B. D.. et al. Oral disopyramid in prophylaxis of arrhythmias following myocardial infarction. Lancet 1976; 1: 51
    PubMedGoogle Scholar
  • 66 Aschuff S. C., Campbell R. W.. et al. Mexiletine in the prevention of ventricular dysrhythmias in acute myocardial infarction. Circulation 1975; 51/52 (Suppl. II) 147
    PubMedGoogle Scholar
  • 67 Merx W., Franken G., Effert S.. Mexitil beim akuten Herzinfarkt. Z. Kardiol. 1980; 69: 204
    PubMedGoogle Scholar
  • 68 Kosowsky B. D., Taylor J., Lown B., Ritchie R. T.. Long-term use of procainamid following acute myocardial infarction. Circulation 1973; 47: 1204-1210
    CrossrefPubMedGoogle Scholar
  • 69 Collaborative Group Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients. Lancet 2. 1971; 1055-1057
    PubMedGoogle Scholar
  • 70 Vajda F. J. E., Prineas R. J., Lovell R. R. H., Sloman J. G.. The possible effect of longterm high plasma levels of phenytoin on mortality after acute myocardial infarction. Europ. J. Clin. Pharmacol. 1973; 5: 138
    CrossrefPubMedGoogle Scholar
  • 71 Lovell R. R. H.. Review of the present status of drug treatment for preventing sudden death. Brit. Heart J. 40 (Suppl.) 1978; 94-98
    PubMedGoogle Scholar
  • 72 Peter Th., Ross D.. et al. Effect on survival after myocardial infarction of longterm treatment with phenytoin. Brit. Heart J. 1978; 40: 1356-1360
    CrossrefPubMedGoogle Scholar
  • 73 van Durme J. P., Bogaert M. G.. Prevention of sudden death: The role of antiarrhythmic therapy. In Kulbertus H. E., Wellens H. J. J.. (eds) Sudden death. Martinus Nijhoff-Publishers The Hague, Boston; London: 1980: 324-327
    Google Scholar
  • 74 Hagemeijer F., Glaser B., van Durme J. P., Bogaert M.. Design of a study to evaluate drug therapy of serious ventricular rhythm disturbances after an acute myocardial infarction. Europ. J. Cardiol. 1977; 6: 299-310
    PubMedGoogle Scholar
  • 75 Chamberlain D. A.. Oral mexiletine in high risk patients after acute myocardial infarction. VIII European Congress of Cardiology, Paris, 217 (abstr) 1980
    PubMedGoogle Scholar
  • 76 Campbell N. P. S., Pantridge J. T., Adgey A. A. J.. Longterm oral antiarrhythmic therapy with mexitil. Brit. Heart. J. 1978; 40: 796-801
    CrossrefPubMedGoogle Scholar
  • 77 Lichtlen P. R., Bethge K. P., Godt U.. Zum Problem der antiarrhythmischen Langzeittherapie nach Infarkt. In Gross F.. Neue Aspekte der medikamentösen Behandlung des Herzinfarktes. Hans Huber Bern, Stuttgart; Wien: 1980: 201-219
    Google Scholar
  • 78 Breithardt G., Seipel L., Loogen F.. Der akute Herztod - Bedeutung elektrophysiologischer Stimulationsverfahren. Verh. dtsch. Ges. Herz- u. Kreislaufforschg. 1980; 46: 38-64
    PubMedGoogle Scholar
  • 79 Engel T. R., Mendizabal R., Meister S. G., Bentivoglio L. G.. Testing for ventricular tachycardia with programmed extrasystoles in sinus rhythm. Circulation 1975; 52 (Suppl. II) 178
    PubMedGoogle Scholar
  • 80 Horowitz L. N., Josephson M. E., Farshidi A.. et al. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimes. Circulation 1978; 58: 986
    CrossrefPubMedGoogle Scholar
  • 81 Mason J. W., Winkle R. A.. Electrode - catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 1978; 58: 971
    CrossrefPubMedGoogle Scholar
  • 82 Ruskin J. N., di Marco J. P., Garan H.. Out of hospital cardiac arrest. electrophysiologic observations and selecting of long term antiarrhythmic therapy. New Engl. J. Med. 1980; 303: 607-613
    PubMedGoogle Scholar
  • 83 Warnowicz M. A., Denes P.. Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity. Progr. Cardiovasc. Dis. 1980; 23: 225-236
    CrossrefPubMedGoogle Scholar
  • 84 Zipes D. P.. New approaches to antiarrhythmic therapy. New Engl. J. Med. 1981; 304: 475-476
    CrossrefPubMedGoogle Scholar
  • 85 Wellens H. J. J., Bär F.. Clinical relevance of tachycardias induced during programmed cardiac stimulation. Am. J. Cardiol. 1979; 43: 400 (abstr.)
    PubMedGoogle Scholar
  • 86 Fisher D. H.. Ventricular tachycardia - practical and provocative electrophysiology (editorial):. Circulation 1978; 58: 1000
    CrossrefPubMedGoogle Scholar
  • 87 Breithardt G., Seipel L., Haerten H., Abend-rot L., Loogen R.. Effektivitätskontrolle der antiarrhythmischen Therapie bei Patienten mit chronisch rezidivierenden, ventrikulären Tachykardien mittels elektrophysiologischer Stimulationsverfahren. Z. Kardiol. 1979; 68: 725
    PubMedGoogle Scholar
  • 88 Collins jr. J. J.. Surgery for intractable ventricular arrhythmias. New Engl. J. Med. 1980; 302: 627-628
    CrossrefPubMedGoogle Scholar
  • 89 Fontaine G., Frank R., Guiraudon G.. et al. Surgical treatment of resistant reentrant ventricular tachycardia by ventriculotomy. A new application of epicardial mapping. Circulation 1974; 49/50 (Suppl. III) 82
    PubMedGoogle Scholar
  • 90 Guiraudon G., Fontaine G., Frank R.. Circular endocardial ventriculotomie.A new surgical treatment for life threatening ventricular tachycardia resistant to medical treatment following myocardial infarction. Ann. Thoracic. Surg. 1978; 26: 438
    CrossrefPubMedGoogle Scholar
  • 91 Kaiser G. A., Waldo A. L., Beach P. M.. et al. Specialized cardiac conduction-system. Improved electrophysiologic identification technique at surgery. Arch. Surg. 1970; 101: 673
    CrossrefPubMedGoogle Scholar
  • 92 Lown B., Th B.Graboys. Management of patients with malignant ventricular arrhythmias. Am. J. Cardiol. 1977; 39: 910-918
    CrossrefPubMedGoogle Scholar
  • 93 Hjalmarson A.. Prevention of sudden death. The role of Betablockers. In Kulbertus H. E., Wellens H. J. J.. Sudden death. Martinus Nijhoff-Publishers. The Hague; Bosten, London: 1980: 313-323
    Google Scholar
  • 94 A Multicenter International Study Improvement in prognosis of myocardial infarction by longterm betaadrenoreceptor blockade using practolol. Brit. med. J. 1977; 735-740 III
    PubMedGoogle Scholar
  • 95 Multicentre International Study Supplementary report: Reduction in mortality after myocardial infarction with longterm betaadrenoreceptor-blockade (K. G. Green). Brit. med. J. 1977; II 419-421
    PubMedGoogle Scholar
  • 96 Schröder R.. Prävention des Reinfarktes und des plötzlichen Herztodes. In Gross F.. Neue Aspekte der medikamentösen Behandlung des Herzinfarktes. Hans Huber, Bern; Stuttgart, Wien: 1980: 165-177
    Google Scholar
  • 97 Barber J. M., Boyle M. C.. et al. Practolol in acute myocardial infarction. Acta med. Scand. Suppl. 1976; 587: 213-216
    PubMedGoogle Scholar
  • 98 Ahlmark G., Saetre H.. Longterm treatment with betablockers after myocardial infarction. Europ. J. Clin. Pharmacol. 1976; 10: 77
    CrossrefPubMedGoogle Scholar
  • 99 Ahlmark G., Saetre H., Korsgren M.. Reduction of sudden death after myocardial infarction. Lancet 1974; 2: 1563
    PubMedGoogle Scholar
  • 100 Andersen M. P., Bechsgaard P., Frederikse J.. et al. Effect of alprenolol on mortality among patients with definitive or suspected myocardial infarction. Preliminary results. Lancet 1979; 2: 865-868
    PubMedGoogle Scholar
  • 101 Reynolds J. L., Whitelock R. M. L.. Effects of a beta adrenergic receptorblocker in myocardial infarction treated for one year from onset. Brit. Heart J. 1972; 34: 252
    CrossrefPubMedGoogle Scholar
  • 102 Wilhelmsson C, Vedin J. A., Wilhemsen L., Tibblin G., Werkö L.. Reduction of sudden death after myocardial infarction by treatment with alprenolol. Lancet 1974; 2: 1157
    PubMedGoogle Scholar
  • 103 Vedin A., Wilhelmsson C., Tibblin G., Werkö L.. Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital. Acta. med. Scand. Suppl. 1975; 575: 7
    PubMedGoogle Scholar
  • 104 Baber N. S.. et al. Multicentre postinfarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Brit. Heart J. 1980; 44: 96-100
    CrossrefPubMedGoogle Scholar
  • 105 Sloman G., Stannard M.. Beta adrenergic blockade and cardiac arrhythmia. Brit. med. J. 1967; 508. IV
    PubMedGoogle Scholar
  • 106 Winkle R. A., Gradman A. H., Fitzgerald J. W.. Antiarrhythmic drug effect assessed from ventri-cular anhythmia reduction in the ambulatory electrocardiogram and tread mill test: Comparison of propranolol, procainamid and quinidine. Am. J. Cardiol. 1978; 42: 473
    CrossrefPubMedGoogle Scholar
  • 107 Sinn R., Wolf R., Pretschner P., Hundesha-gen H., Koeffler H., Dopslaff H.. Häufigkeit und Bedeutung ventrikulärer Arrhythmien unter medikamentöser Prophylaxe nach Myocardinfarkt. Z. Kardiol. 1980; 69: 225
    PubMedGoogle Scholar
  • 108 Godt U., Bethge K. P., Lichtlen P. R.. Rhythmusstörungen und plötzlicher Herztod im frühen Postinfarktstadium. Z. Kardiol. 1980; 69: 226
    PubMedGoogle Scholar
  • 109 Wellens H. J. J., Bär F., Lie K. J.. et al. Effect of procainamid, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia. Am. J. Cardiol. 1977; 40: 579
    CrossrefPubMedGoogle Scholar
  • 110 Ritchie J. L., Harker L. A.. The possible role of platelets in sudden cardiac death. In Kulbertus H. E., Wellens H. J. J.. Sudden death. Martinus Nijhoff-Publishers; The Hague, Boston, London: 1980: 328-334
    Google Scholar
  • 111 Overschl K. W., So Baedecker C. S.. Wirkung von Betarezeptorenblockern auf die Thrombozytenaggregation bei coronarer Herzkrankheit. Z. Kardiol. Suppl. 1978; 5: 78
    PubMedGoogle Scholar
  • 112 Sherry S.. The Anturan Reinfarction Trial. Circulation 1980; 62: 73-78 (Suppl/V)
    PubMedGoogle Scholar
  • 113 Gülker R. F., Bender J.Thaler, Heuer R., Dorsel T., Pierchalter P.. Fehlende antiarrhythmische und antifibrillatorische Wirkung von Sul-finpyrazolon beim akuten Myocardinfarkt. Z. Kardiol. 1980; 69: 206
    PubMedGoogle Scholar
  • 114 Moschos C., Escobias A., Jorgensen O., Regan T.. Effect of sulfinpyrazon on survival following experimental non thrombotic coronary occlusion. Am. J. Cardiol. 1979; 43: 372
    PubMedGoogle Scholar
  • 115 Wilcox R. G., Richardson D., Hampton J. R., Mitchell J. R. A., Banks D. C.. Sulfinpyrazon in acute myocardial infarction: Studies on cardiac rhythm and renal function. Brit. med. J. 1980; 281: 531
    CrossrefPubMedGoogle Scholar